SAVE THE DATE
Date: 23-27 July, 2018
Prof Yehuda Carmeli, MD, MPH, heads the Israeli National Center for Antibiotic Resistance and Infection Control, and the Division of Epidemiology at the Tel Aviv Medical Center, in Tel Aviv, Israel. He is also on the research staff at the Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.
Prof Carmeli received his MD degree from Ben Gurion University, Israel and his MPH degree at Harvard School of Public Health. He served his residency at Hadassah Medical Center, Hebrew University, Jerusalem, and then served as a fellow in Medicine at Massachusetts General Hospital, Boston. Dr. Carmeli completed his fellowship in Infectious Diseases at Beth Israel Deaconess Medical Center.
Prof Carmeli is the recipient of the Finland research award of the Massachusetts Infectious Disease Society, and the John T Smith award on research of new quinolones, and The ICAAC program award for Pathogenesis of Microbial Diseases. He was nominated as the chair of the Advisory Committee to the Israeli Ministry of Health on Nosocomial Infections and Antimicrobial Resistance.
His primary research interest is the epidemiology of resistance to antibiotics.
Prof Carmeli will be visiting Melbourne and Austin Health in July 2018 as a guest of the Melbourne Genomics Health Alliance Flagship "Controlling Superbugs".
SAVE THE DATE
Date: 3rd November 2018, 8:30-5:30PM
Venue: Austin Health, Heidelberg, Victoria
Registration: Opens 18th June 2018 (Closes 29th October 2018)
A single-day program providing an update on antibiotic allergy practice and dedicated workshops focused on the implementation of antibiotic allergy testing into pharmacy, infectious diseases and hospital antimicrobial stewardship practice.
Invited international speaker
Professor Elizabeth Phillips - Professor of Medicine, Department of Infectious Diseases, Vanderbilt University Medical Centre, Nashville, USA.
Invited local speakers
Dr Jason Trubiano – Director of AMS and Antibiotic Allergy Services, Austin Health & University of Melbourne
Prof Connie Katelaris – Professor of Allergy and Immunology, Western Sydney University
Dr James Yun – Allergist/Immunologist, University of Sydney
Dr Natasha Holmes – Infectious diseases and antibiotic allergy physician, Austin Health
SAVE THE DATE
Date: 29-31 October, 2018
Each year the Melbourne Infectious Diseases Group (MIDG) invites an outstanding ID clinician to visit Melbourne as the “Forbes Fellow” to attend a number of the key teaching hospitals, comment on interesting cases and present a number of cutting-edge lectures.
The Forbes Fellowship is named after Dr. John Forbes who was the longstanding Director of Fairfield Infectious Diseases Hospital in Melbourne, and although Fairfield closed some years ago, the Fellowship continues in his honour.
The Forbes Fellow for 2018 is Professor Marc Mendelssohn.
Prof Marc Mendelson studied Medicine at St Mary’s Hospital, London and specialized in Infectious Diseases at Addenbrookes Hospital, Cambridge, where he attained his PhD in cytomegalovirus latency. Marc undertook post-doctoral studies at The Rockefeller University, New York, working on the interaction between Mycobacterium tuberculosis and dendritic cells, before transferring his research to Cape Town. He is now Professor of Infectious Diseases and head of Division of Infectious Diseases & HIV Medicine at Groote Schuur Hospital, University of Cape Town, and Director of the Cape Town GeoSentinel Travel Surveillance Network Site. He is past-President of the Infectious Diseases Society of Southern Africa, and the Federation of Infectious Diseases Societies of Southern Africa. He is President of the International Society for Infectious Diseases (ISID).
His main field of interest lies is national and international policy related to Antimicrobial Resistance. He is Chair of the South African Ministerial Advisory Committee on AMR, South African lead for the Global Health Security Agenda Prevent-1 AMR working group, Director of the South African National Antibiotic Stewardship Training Centre, and a member of the scientific advisory committee of the Global Antibiotic Research & Development Programme (GARDP). Marc is a technical advisor to WHO on a variety of AMR-related projects.